Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In vitro and in vivo growth characteristics of a new ascites-type neuroblastoma cell from mouse C1300 neuroblastoma.

Neurochemistry international·2010
Same author

Inhibition by neuroblastoma growth inhibitory factor of ascites-type neuroblastoma cell growth in coculture with normal glioblasts.

Neurochemistry international·2010
Same author

Potentiation by BL191 of differentiation of neuroblastoma cells induced by dibutyryl cAMP and prostaglandin E(1).

Neurochemistry international·2010
Same author

Preparation and enzymatic recognition of guanine lesions induced by nitrogen oxides.

Nucleic acids symposium series·2003
Same author

Quantitation of DNA damage by an aldehyde reactive probe (ARP).

Nucleic acids research. Supplement (2001)·2003
Same author

Oxidation of thymine to 5-formyluracil in DNA promotes misincorporation of dGMP and subsequent elongation of a mismatched primer terminus by DNA polymerase.

The Journal of biological chemistry·2001

Related Experiment Video

Updated: Jul 26, 2026

Complete Thymectomy in Adult Rats with Non-invasive Endotracheal Intubation
08:35

Complete Thymectomy in Adult Rats with Non-invasive Endotracheal Intubation

Published on: December 29, 2014

Extended trans-sternal thymectomy for myasthenia gravis.

A Masaoka1

  • 1Department of Surgery II, Nagoya City University Medical School, Nagoya, Japan.

Chest Surgery Clinics of North America
|June 21, 2001
PubMed
Summary

Extended thymectomy is a widely accepted and stable procedure for thymic tissue removal. Maximal thymectomy, despite higher tissue removal rates, does not yield superior results, possibly due to minimal additional tissue gain.

Area of Science:

  • Thoracic Surgery
  • Surgical Oncology

Background:

  • Thymectomy is a surgical procedure involving the removal of the thymus gland.
  • Different surgical approaches exist for thymectomy, with varying degrees of thymic tissue removal.
  • The completeness of thymic tissue removal is a critical factor influencing surgical outcomes.

Purpose of the Study:

  • To compare the effectiveness of different thymectomy procedures based on the completeness of thymic tissue removal.
  • To investigate why maximal thymectomy does not consistently outperform extended thymectomy.

Main Methods:

  • Review of existing literature and surgical outcome data.
  • Classification of thymectomy procedures based on Jaretzki's grading of thymic tissue removal completeness.
  • Analysis of results associated with different thymectomy techniques.

More Related Videos

Gasless Endoscopic Thyroidectomy via the Trans-Axillary Approach
05:10

Gasless Endoscopic Thyroidectomy via the Trans-Axillary Approach

Published on: September 15, 2023

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
04:09

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter

Published on: September 20, 2024

Related Experiment Videos

Last Updated: Jul 26, 2026

Complete Thymectomy in Adult Rats with Non-invasive Endotracheal Intubation
08:35

Complete Thymectomy in Adult Rats with Non-invasive Endotracheal Intubation

Published on: December 29, 2014

Gasless Endoscopic Thyroidectomy via the Trans-Axillary Approach
05:10

Gasless Endoscopic Thyroidectomy via the Trans-Axillary Approach

Published on: September 15, 2023

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
04:09

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter

Published on: September 20, 2024

Main Results:

  • Extended thymectomy (85-95% removal) is the most widely accepted procedure with prominent and stable results.
  • Maximal thymectomy (98-100% removal) does not demonstrate superior outcomes compared to extended thymectomy.
  • The results of thymectomy do not always correlate directly with the percentage of thymic tissue removed.

Conclusions:

  • Extended thymectomy offers a reliable and effective approach for thymectomy.
  • Further investigation is needed to understand the factors contributing to the outcomes of maximal thymectomy, potentially related to minimal incremental tissue removal.